CGTX
Cognition Therapeutics Inc
0.9384$
+0.2%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Cognition Therapeutics Inc (CGTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -3.1 | -3.4 | -3.6 | -19 | -16 | -28 | -25 | |
| 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | |
| 0.0 | 0.5 | 5.2 | 3.6 | 4.4 | 3.7 | 2.1 | |
| 0.6 | 0.4 | 4.8 | 3.6 | – | – | – | |
| 0.6 | 3.1 | 2.8 | -0.9 | 4.8 | 1.3 | -3.5 | |
| 0.1 | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.0 | |
| -0.1 | 0.0 | 0.0 | -0.2 | -0.1 | 0.0 | 0.0 | |
| – | – | – | 6.9 | – | – | – | |
| 2.8 | 5.8 | -0.3 | -1.4 | -0.8 | -0.7 | -0.4 | |
| 2.8 | 5.8 | 53 | 5.5 | 4.5 | 24 | 37 | |
| -0.5 | 2.3 | 50 | -13 | -12 | -4.9 | 12 | |
| -3.2 | -3.4 | -3.7 | -19 | -16 | -28 | -25 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.